DK0494996T3 - Eroderbare makroporøse hydrogelpartikler og fremstilling heraf - Google Patents

Eroderbare makroporøse hydrogelpartikler og fremstilling heraf

Info

Publication number
DK0494996T3
DK0494996T3 DK90916604.3T DK90916604T DK0494996T3 DK 0494996 T3 DK0494996 T3 DK 0494996T3 DK 90916604 T DK90916604 T DK 90916604T DK 0494996 T3 DK0494996 T3 DK 0494996T3
Authority
DK
Denmark
Prior art keywords
hydrogel particles
erodable
preparation
macroporous hydrogel
active agent
Prior art date
Application number
DK90916604.3T
Other languages
Danish (da)
English (en)
Inventor
Robert P Eury
Original Assignee
Advanced Polymer Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Polymer Systems Inc filed Critical Advanced Polymer Systems Inc
Application granted granted Critical
Publication of DK0494996T3 publication Critical patent/DK0494996T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90916604.3T 1989-10-03 1990-09-28 Eroderbare makroporøse hydrogelpartikler og fremstilling heraf DK0494996T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41656789A 1989-10-03 1989-10-03

Publications (1)

Publication Number Publication Date
DK0494996T3 true DK0494996T3 (da) 1996-03-18

Family

ID=23650468

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90916604.3T DK0494996T3 (da) 1989-10-03 1990-09-28 Eroderbare makroporøse hydrogelpartikler og fremstilling heraf

Country Status (11)

Country Link
EP (1) EP0494996B1 (es)
JP (1) JP2980978B2 (es)
KR (1) KR920703016A (es)
AT (1) ATE131726T1 (es)
AU (1) AU646414B2 (es)
CA (1) CA2066594A1 (es)
DE (1) DE69024363T2 (es)
DK (1) DK0494996T3 (es)
ES (1) ES2083467T3 (es)
HK (1) HK1007109A1 (es)
WO (1) WO1991004732A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0842132T3 (da) * 1995-07-28 2000-10-16 Du Pont På vand flydende partikelformige materialer, der indeholder mikronæringsstoffer til fytoplankton
US5851538A (en) * 1995-12-29 1998-12-22 Advanced Polymer Systems, Inc. Retinoid formulations in porous microspheres for reduced irritation and enhanced stability
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
DE19622355A1 (de) 1996-06-04 1997-12-11 Bayer Ag Formkörper die agrochemische Mittel freisetzen
GB9621825D0 (en) * 1996-10-19 1996-12-11 Andaris Ltd Microparticles and their use as therapeutic vehicles
US20030008926A1 (en) * 1997-04-30 2003-01-09 Mcpartland Tor Ant spray containing D-limonene and methods of making and using same
US20020004502A1 (en) 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
US6878384B2 (en) 2001-03-13 2005-04-12 Microvention, Inc. Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use
CN101500623B (zh) 2006-06-15 2016-08-24 微温森公司 一种由可膨胀聚合物构成的栓塞器械
CA2709379C (en) 2007-12-21 2016-08-16 Microvention, Inc. Hydrogel filaments for biomedical uses
WO2009108760A2 (en) * 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
CA2777171C (en) 2009-10-26 2017-09-19 Microvention, Inc. Embolization device constructed from expansile polymer
WO2012145431A2 (en) 2011-04-18 2012-10-26 Microvention, Inc. Embolic devices
US10226533B2 (en) 2014-04-29 2019-03-12 Microvention, Inc. Polymer filaments including pharmaceutical agents and delivering same
WO2016201250A1 (en) 2015-06-11 2016-12-15 Microvention, Inc. Expansile device for implantation
CN114384227A (zh) * 2021-06-16 2022-04-22 西安石油大学 一种致密砂岩的准连续溶蚀-胶结作用致密机理测定方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
JP2793188B2 (ja) * 1986-08-15 1998-09-03 アドバンスト ポリマー システムズ,インコーポレイティド ポリマー担体組成物の製造方法
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4806360A (en) * 1987-10-23 1989-02-21 Advanced Polymer Systems Synthetic melanin aggregates

Also Published As

Publication number Publication date
EP0494996A1 (en) 1992-07-22
HK1007109A1 (en) 1999-04-01
ATE131726T1 (de) 1996-01-15
EP0494996B1 (en) 1995-12-20
ES2083467T3 (es) 1996-04-16
WO1991004732A1 (en) 1991-04-18
DE69024363D1 (de) 1996-02-01
DE69024363T2 (de) 1996-07-04
AU646414B2 (en) 1994-02-24
EP0494996A4 (en) 1992-09-30
AU6715690A (en) 1991-04-28
CA2066594A1 (en) 1991-04-04
JPH05500959A (ja) 1993-02-25
KR920703016A (ko) 1992-12-17
JP2980978B2 (ja) 1999-11-22

Similar Documents

Publication Publication Date Title
DK0494996T3 (da) Eroderbare makroporøse hydrogelpartikler og fremstilling heraf
DK164256C (da) Praeparat med kontrolleret afgivelse og fremgangsmaade til fremstilling heraf
BR9707336A (pt) Dosagem contínua de um agente ativo medainte uso de sistema implantável
FI965203A0 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
BR8606003A (pt) Composicoes de liberacao prolongada compreendendo eteres de hidroxipropil celulose
ES2154737T3 (es) Proceso para preparar formas de dosificacion farmaceutica solidas de substancias hidrofobicas.
MX9600857A (es) Forma de dosificacion i en tabletas, con unidades multiples.
DE3163877D1 (en) Membrane modified hydrogels, process for their manufacture and their use as active agent dispenser
MX27046A (es) 5-arilalquil-4-alcoxy-2(5h)-furanonas, productos intermedios y procedimiento para su preparacion asi como su aplicacion como sustancia activa terapeutica.
DK344586D0 (da) Tidskontrolleret laegemiddelafgivelse
PL247289A1 (en) Method of making a divisible tablet of controllable and delayed release of active substance
AR008991A1 (es) Compuestos de dimetil-(3-aril-but-3-enil)-amina, procedimientos para su preparacion y aplicacion de los mismos
IT1230047B (it) Protesi vascolare contenente nella parete microcapsule inglobanti cellule produttrici di ormoni.
GB2207052B (en) Controlled-release device
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
EP0145210A3 (en) Support particles coated with precursors biologically active glass
IT8121849A0 (it) Procedimento per la preparazione di un agente anti-microbico, composizioni che lo contengono eloro uso nel trattamento di infezioni.
WO1996015660A3 (de) Implantierbare vorrichtung zur verabreichung von wirkstoffen an pflanzen
ATE68686T1 (de) System zum freigeben von stoffen in der vagina.
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
IT1294931B1 (it) Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
ES8605982A1 (es) Procedimiento para producir preparados de agentes antihelminticos dificilmente solubles en agua
ES2190581T3 (es) 2-aminotetralina opticamente activa, procedimiento para su preparacion y composiciones farmaceuticas que la contienen, activa en la prevencion y tratamiento de shock septico.
HUP0103623A3 (en) Bispiperidines as antithrombotic agents, their process for preparation and medicament containing them as active ingredient